Skip to main content
Microbiology (USP <61>/<62>)

The Microbiology Problem No One Talks About in Herbal Raw Material Sourcing

Herbal raw materials can harbor Salmonella without visible signs. Learn what USP <61>/<62> testing covers and why your supplier COA often falls short.

Nour Abochama VP Operations, Qalitex | Quality Consultant, Ayah Labs

Key Takeaway

Herbal raw materials can harbor Salmonella without visible signs. Learn what USP <61>/<62> testing covers and why your supplier COA often falls short.

Salmonella does not need moisture to wait you out. In dried botanical material — turmeric, ashwagandha, black cohosh, elderberry — the pathogen can survive for months at water activity levels below 0.20, far drier than anything your incoming COA will flag. It produces no gas, no odor, no visible change to the powder. And if your incoming quality process ends at reviewing a supplier’s test report, you have a gap.

This is the microbiology problem that doesn’t get enough airtime in the herbal ingredient space. The conversation tends to focus on adulteration and heavy metals — both real issues, both worth serious attention. But microbial contamination in botanical raw materials causes actual consumer harm, triggers FDA recalls, and often stems from testing failures that are entirely preventable.

For Midwest supplement brands sourcing herbal raw materials domestically or from overseas, the gap between a supplier’s certificate of analysis and a USP-compliant microbiology result is wider than most quality teams realize.

Dried Botanicals Are Not Shelf-Stable — Not Microbiologically, Anyway

There’s a persistent assumption in this industry that “dried” means “microbiologically safe.” It doesn’t. Low water activity (Aw) slows microbial growth, but it doesn’t sterilize. Most dried botanicals arrive with an Aw between 0.50 and 0.70 — which inhibits active bacterial replication but still permits mold colonization. Aspergillus species, including aflatoxin-producing strains like A. flavus and A. parasiticus, can establish at Aw values as low as 0.73.

The field contamination story starts well before the material reaches your warehouse. Botanical crops are harvested in soil environments where E. coli, Salmonella, and Bacillus cereus are endemic. Poorly controlled drying — whether sun-drying in the field or industrial rotary drum drying at temperatures insufficient to reduce pathogen load — can lock contamination into the matrix. Improper storage or prolonged transit compounds it. By the time the material arrives at a Chicago receiving dock and someone tears open the sack to pull a sample, the microbial picture could look nothing like what the overseas supplier tested six weeks ago.

The complicating factor is that dried plant matrices are notoriously difficult to test accurately. High tannin content in some botanicals — green tea, oak bark, witch hazel — can inhibit the growth media used in standard microbiological assays, producing falsely low counts. Aromatic oils in herbs like oregano and thyme have intrinsic antimicrobial properties that suppress indicator organisms in test samples, making a batch look cleaner than it actually is while pathogens with different susceptibility profiles persist. Legitimate analytical testing labs run neutralization steps and validated matrix-specific methods to account for this. Many supplier labs do not.

What USP <61> and <62> Testing Actually Covers

USP <61> — Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests — quantifies the total microbial load in a sample. The chapter defines methods for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) using the pour plate method, the surface spread method, or membrane filtration. The result is a CFU-per-gram number that tells you how many organisms are present, not which ones.

USP <62> — Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms — answers the “which ones” question. It provides validated methods for detecting specific pathogens: Salmonella species, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, bile-tolerant gram-negative bacteria, and Candida albicans. For oral herbal preparations, USP General Chapter <2031> defines the acceptance criteria that apply: Salmonella absent in 25g, E. coli absent in 1g, bile-tolerant gram-negatives ≤ 10³ CFU/g, TAMC ≤ 10⁵ CFU/g, and TYMC ≤ 10³ CFU/g.

A few things worth understanding about how these tests actually work in practice:

Sample size matters enormously. Detecting Salmonella at the 25g threshold requires proper pre-enrichment in buffered peptone water, selective enrichment in Rappaport-Vassiliadis broth, and confirmatory biochemical and serological testing. The full procedure takes a minimum of five working days when run correctly. Suppliers who turn around a COA in 24 to 48 hours either used a rapid screening method or didn’t test for Salmonella at all.

Method suitability validation is non-negotiable for botanical matrices. Before any count or presence/absence result is reportable under the USP framework, the laboratory must demonstrate that the test method performs correctly in the specific sample matrix. This is method suitability testing — required under both <61> and <62>. Without it, a TAMC of 100 CFU/g on a high-tannin botanical could reflect matrix suppression of a true count closer to 10⁵ CFU/g.

Rapid microbiological methods are gaining traction, particularly ATP bioluminescence and PCR-based pathogen screening for Salmonella. These approaches compress turnaround time meaningfully. But they still require validation against the compendial reference methods, and a PCR screen alone doesn’t substitute for the full USP <62> specified organism battery in a regulatory context.

Why Your Supplier’s COA Doesn’t Tell the Whole Story

This is the uncomfortable part. Overseas suppliers — particularly in high-volume botanical production regions — frequently issue COAs that report microbiology results using methods that aren’t equivalent to USP <61>/<62>. Common gaps we see when reviewing incoming documentation:

  • Total plate count incubated at 25°C rather than the 30–35°C incubation required by USP <61> for TAMC. Lower temperatures underestimate mesophilic bacterial load.
  • TYMC reported as “total mold count” without the yeast fraction — missing Candida and osmophilic yeasts relevant to oral products.
  • Salmonella listed as “ND” with a 1g or 5g sample size, not the 25g called for in USP <2031>. Statistical detection probability at that mass is insufficient to make a valid absence claim.
  • Results in “TVC per gram” with no method, temperature, or incubation time documented — uninterpretable from a USP compliance standpoint.

None of this makes a supplier fraudulent. It often reflects different standards — ISO 4833 for TAMC, ISO 21527 for yeast and mold — that are widely accepted in food-grade contexts but don’t map cleanly onto USP expectations for dietary supplement raw materials.

Under 21 CFR Part 111.75, a supplement manufacturer is responsible for testing incoming raw materials against established specifications before using them in production. The regulation doesn’t allow you to rely solely on a supplier COA to establish purity or microbial compliance — unless you have an independently verified history of that supplier’s testing performance. That means the microbiology test needs to happen in your facility, or at an analytical testing laboratory running USP-compliant methods, before the material goes into your blend room. FDA warning letters issued under 21 CFR Part 111 consistently cite failure to establish and follow written procedures for component testing, and microbial limits are among the most frequently flagged gaps.

Building a Microbiology Specification That Holds Up to FDA Scrutiny

For Midwest supplement brands bringing botanical products to market under DSHEA, a defensible raw material microbiology specification has a few non-negotiable elements.

Start with USP <2031> as your baseline. Don’t invent limits from scratch. The chapter provides acceptance criteria organized by route of administration and product type. For oral herbal preparations: TAMC ≤ 10⁵ CFU/g, TYMC ≤ 10³ CFU/g, E. coli absent in 1g, Salmonella absent in 25g. If your raw material specification is tighter — which is appropriate for higher-risk botanicals — document the rationale in your specification record.

Require USP method designation on every incoming COA. Ask suppliers explicitly: which USP chapter was used? Was method suitability demonstrated in this matrix? That question alone will reveal a great deal about a supplier’s quality system — and whether their result is actually comparable to what a USP-compliant lab would report.

Test every lot from new suppliers, and every third to fifth lot from qualified suppliers. Seasonal variation in crop contamination is real — a supplier qualified on spring harvest material may deliver fall harvest with a markedly different microbial profile. The tighter your incoming surveillance cadence, the faster you’ll catch drift before it becomes a nonconformance event.

Send samples to an ISO 17025-accredited analytical testing laboratory running validated USP methods. Accreditation means the lab’s methods are validated, equipment is calibrated, and results are defensible during an FDA inspection. This matters if an investigator asks how you verified a raw material met your specification.

For brands in the Chicago area, having a nearby receiving hub where samples can be logged, split, and dispatched to an accredited lab without a cross-country cold chain adds real efficiency to the process — and shrinks the time between receipt and release decision.

One Thing You Can Do This Week

Pull the last five COAs from your primary botanical supplier and check three things: whether Salmonella was tested in a 25g sample, whether method suitability for your matrix type is documented, and whether incubation conditions are specified. If any of those three are missing or unclear, that’s the conversation to have before the next shipment arrives.

Microbiology isn’t the most visible part of raw material qualification. But it’s one of the few areas where a gap in incoming testing can result in a consumer illness, a voluntary recall, and a year of rebuilding trust with retailers and customers you spent years to win.


Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Nour Abochama

Written by

Nour Abochama

VP Operations, Qalitex | Quality Consultant, Ayah Labs

Chemical engineer with 17+ years of experience in laboratory operations, quality assurance, and regulatory compliance. Expert in herbal and supplement testing, botanical identity, contract laboratory services, and ISO 17025 quality systems. Master's in Biomedical Engineering from Grenoble INP – Ense3. Former Director of Quality at American Testing Labs and Labofine. Executive Producer and co-host of the Nourify-Beautify Podcast.

Chemical Engineering17+ Years Lab OperationsISO 17025 (via Qalitex)Herbal & Supplement Testing Specialist
View LinkedIn Profile →

Need contract testing?

Get a quote from Ayah Labs. 48-hour turnaround for chemistry tests. Signed CoA included.

Get a Testing Quote →